Logo image of NOTV

INOTIV INC (NOTV) Stock Price, Quote, News and Overview

NASDAQ:NOTV - Nasdaq - US45783Q1004 - Common Stock - Currency: USD

4.49  +0.06 (+1.35%)

Premarket: 4.45 -0.04 (-0.89%)

NOTV Quote, Performance and Key Statistics

INOTIV INC

NASDAQ:NOTV (2/4/2025, 8:00:01 PM)

Premarket: 4.45 -0.04 (-0.89%)

4.49

+0.06 (+1.35%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High11.42
52 Week Low1.23
Market Cap143.77M
Shares32.02M
Float28.17M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)02-05 2025-02-05/amc
IPO11-25 1997-11-25


NOTV short term performance overview.The bars show the price performance of NOTV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

NOTV long term performance overview.The bars show the price performance of NOTV in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NOTV is 4.49 USD. In the past month the price decreased by -10.74%. In the past year, price decreased by -9.48%.

INOTIV INC / NOTV Daily stock chart

NOTV Latest News, Press Releases and Analysis

News Image
14 days ago - Inotiv, Inc.

Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research...

News Image
a month ago - Inotiv, Inc.

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...

News Image
a month ago - Inotiv, Inc.

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...

News Image
2 months ago - Inotiv, Inc.

Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...

News Image
2 months ago - Inotiv, Inc.

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...

NOTV Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.56 222.07B
DHR DANAHER CORP 28.71 155.30B
A AGILENT TECHNOLOGIES INC 27.8 41.93B
IQV IQVIA HOLDINGS INC 18.42 36.31B
MTD METTLER-TOLEDO INTERNATIONAL 35.12 28.27B
WAT WATERS CORP 36.03 24.37B
WST WEST PHARMACEUTICAL SERVICES 48.97 23.97B
ILMN ILLUMINA INC 71.79 19.70B
ICLR ICON PLC 13.78 15.96B
RVTY REVVITY INC 25.13 14.99B
AVTR AVANTOR INC 22.46 14.98B
TECH BIO-TECHNE CORP 40.53 11.53B

About NOTV

Company Profile

NOTV logo image Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,955 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Company Info

INOTIV INC

2701 Kent Ave

West Lafayette INDIANA 47906 US

CEO: Robert W. Leasure Jr.

Employees: 1955

Company Website: https://www.inotivco.com/

Investor Relations: https://www.basinc.com/invest

Phone: 13174634527

NOTV FAQ

What is the stock price of NOTV?

The current stock price of NOTV is 4.49 USD.


What is the symbol for INOTIV INC stock?

The exchange symbol of INOTIV INC is NOTV and it is listed on the Nasdaq exchange.


On which exchange is NOTV stock listed?

NOTV stock is listed on the Nasdaq exchange.


Is NOTV a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NOTV, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NOTV.


Does NOTV stock pay dividends?

NOTV does not pay a dividend.


When does NOTV stock report earnings?

NOTV will report earnings on 2025-02-05, after the market close.


What is the Price/Earnings (PE) ratio of NOTV?

NOTV does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.19).


What is the Short Interest ratio of NOTV stock?

The outstanding short interest for NOTV is 5.37% of its float.


NOTV Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to NOTV. When comparing the yearly performance of all stocks, NOTV is one of the better performing stocks in the market, outperforming 84.05% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NOTV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NOTV Financial Highlights

Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -4.19. The EPS decreased by -1.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -13.88%
ROE -63.6%
Debt/Equity 2.29
Chartmill High Growth Momentum
EPS Q2Q%-92.11%
Sales Q2Q%-7.33%
EPS 1Y (TTM)-1.95%
Revenue 1Y (TTM)-14.29%

NOTV Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to NOTV. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 40.24% and a revenue growth 8.01% for NOTV


Ownership
Inst Owners17.18%
Ins Owners8.84%
Short Float %5.37%
Short Ratio1.47
Analysts
Analysts80
Price Target6.8 (51.45%)
EPS Next Y40.24%
Revenue Next Year8.01%